---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-125040"
form_type: "8-K"
ticker: "BMRN"
cik: "0001048477"
company_name: "BIOMARIN PHARMACEUTICAL INC"
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T17:18:20.242760+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioMarin shareholders approve 8M share increase in equity plan, re-elect all directors

## Summary
- Shareholders approved 8M additional shares under the 2017 Equity Incentive Plan (157.3M for, 7.7M against).
- All ten director nominees, including Elizabeth Anderson and Alexander Hardy, re-elected.
- KPMG ratified as independent auditor for FY2025 with 168.6M votes in favor.
- Advisory vote on executive compensation passed with over 93% support of votes cast.

## SEC filing metadata
- accession: 0001193125-25-125040
- form_type: 8-K
- ticker: BMRN
- cik: 0001048477
- company_name: BIOMARIN PHARMACEUTICAL INC
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/0001193125-25-125040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/d947689d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-125040
- JSON: https://secwatch.observer/filing/0001193125-25-125040.json
- Plain text: https://secwatch.observer/filing/0001193125-25-125040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.